Humacyte IPO

Humacyte is the developer of a biotechnology platform designed to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine.

Total Funding to Date$440MM
Register for Details

For more details on financing and valuation for Humacyte, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in